Sakar Healthcare Limited

NSEI:SAKAR Stock Report

Market Cap: ₹6.4b

Sakar Healthcare Management

Management criteria checks 3/4

Sakar Healthcare's CEO is Sanjay Shah, appointed in Feb 2015, has a tenure of 9.92 years. directly owns 46.02% of the company’s shares, worth ₹2.95B. The average tenure of the management team and the board of directors is 4.3 years and 4.3 years respectively.

Key information

Sanjay Shah

Chief executive officer

₹4.8m

Total compensation

CEO salary percentagen/a
CEO tenure9.9yrs
CEO ownership46.0%
Management average tenure4.3yrs
Board average tenure4.3yrs

Recent management updates

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Mar 02
Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Recent updates

Sakar Healthcare's (NSE:SAKAR) Anemic Earnings Might Be Worse Than You Think

Oct 30
Sakar Healthcare's (NSE:SAKAR) Anemic Earnings Might Be Worse Than You Think

Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Dec 28
Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Aug 05
Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Mar 29
Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Here's Why Sakar Healthcare (NSE:SAKAR) Has Caught The Eye Of Investors

Jan 31
Here's Why Sakar Healthcare (NSE:SAKAR) Has Caught The Eye Of Investors

Is Sakar Healthcare (NSE:SAKAR) Using Too Much Debt?

Dec 01
Is Sakar Healthcare (NSE:SAKAR) Using Too Much Debt?

Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Jul 13
Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Mar 26
Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

With EPS Growth And More, Sakar Healthcare (NSE:SAKAR) Is Interesting

Jul 01
With EPS Growth And More, Sakar Healthcare (NSE:SAKAR) Is Interesting

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today

Mar 23
Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Mar 02
Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Feb 08
Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Jan 10
Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock

Dec 14
Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock

Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?

Nov 22
Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?

CEO Compensation Analysis

How has Sanjay Shah's remuneration changed compared to Sakar Healthcare's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹124m

Jun 30 2024n/an/a

₹112m

Mar 31 2024₹5mn/a

₹117m

Dec 31 2023n/an/a

₹125m

Sep 30 2023n/an/a

₹144m

Jun 30 2023n/an/a

₹127m

Mar 31 2023₹5mn/a

₹128m

Dec 31 2022n/an/a

₹178m

Sep 30 2022n/an/a

₹139m

Jun 30 2022n/an/a

₹144m

Mar 31 2022₹5mn/a

₹152m

Dec 31 2021n/an/a

₹80m

Sep 30 2021n/an/a

₹97m

Jun 30 2021n/an/a

₹118m

Mar 31 2021₹2mn/a

₹107m

Dec 31 2020n/an/a

₹118m

Sep 30 2020n/an/a

₹122m

Jun 30 2020n/an/a

₹106m

Mar 31 2020₹2m₹2m

₹96m

Dec 31 2019n/an/a

₹88m

Sep 30 2019n/an/a

₹86m

Jun 30 2019n/an/a

₹78m

Mar 31 2019₹2m₹2m

₹67m

Compensation vs Market: Sanjay's total compensation ($USD55.80K) is above average for companies of similar size in the Indian market ($USD41.93K).

Compensation vs Earnings: Sanjay's compensation has been consistent with company performance over the past year.


CEO

Sanjay Shah (65 yo)

9.9yrs

Tenure

₹4,800,000

Compensation

Mr. Sanjay Surendra Shah has been Managing Director of Sakar Healthcare Limited since February 1, 2015. Mr. Shah serves as an Executive Director of Sakar Healthcare Limited since March 26, 2004 and serves...


Leadership Team

NamePositionTenureCompensationOwnership
Sanjay Shah
Chairman & MD9.9yrs₹4.80m46.02%
₹ 2.9b
Aarsh Shah
Joint MD & Executive Director12.6yrs₹3.60m6.47%
₹ 414.6m
Sunil Marathe
Technical Director & Whole Time Director1.2yrs₹1.20mno data
Dharmesh Thaker
Chief Financial Officer3.3yrsno datano data
Bharat Soni
Company Secretary & Compliance Officer4.3yrsno datano data

4.3yrs

Average Tenure

34yo

Average Age

Experienced Management: SAKAR's management team is considered experienced (4.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Sanjay Shah
Chairman & MD20.8yrs₹4.80m46.02%
₹ 2.9b
Aarsh Shah
Joint MD & Executive Director12.6yrs₹3.60m6.47%
₹ 414.6m
Sunil Marathe
Technical Director & Whole Time Director1.2yrs₹1.20mno data
Vishalakshi Chandramouli
Non-Executive Non-Independent Director1.3yrsno datano data
Shailesh Patel
Non-Executive Independent Director9.8yrsno datano data
Prashant Srivastav
Independent Non-Executive Director9.8yrsno datano data
Hemendrakumar Shah
Independent Non-Executive Director4.3yrsno datano data
Khyati Shah
Non-Executive Independent Director1.2yrsno datano data
Jignesh Parikh
Non-Executive Independent Director1.2yrsno datano data

4.3yrs

Average Tenure

54yo

Average Age

Experienced Board: SAKAR's board of directors are considered experienced (4.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 19:37
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sakar Healthcare Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution